Achievers & Accolades

UNCP researcher receives $1.1M grant to support breakthrough Alzheimer’s treatment development

By Staff Report, posted 3 months ago

NCInnovation this month approved a $1.1 million grant to back UNC Pembroke researcher Dr. Ben A.Bahr's work on a treatment for Alzheimer's disease.

Dr. Ben A. Bahr, a William C. Friday endowed chair and distinguished professor at UNC Pembroke, and team are working on a new therapeutic compound to treat Alzheimer’s disease, which affects 55 million people worldwide, as well as other brain disorders. Current treatment options are expensive, inaccessible and/or have limited effectiveness. Bahr’s patent-pending compounds work to reduce multiple pathogenic proteins that accumulate in the brains of Alzheimer’s patients.

"Dr. Ben Bahr’s research represents the very best of UNC Pembroke’s mission to serve and innovate," UNC Pembroke Chancellor Robin Cummings said in a press release. "His efforts to develop a new therapeutic compound for Alzheimer’s disease, an illness that impacts millions worldwide, represents the transformative potential of faculty-led research at regional institutions. We are grateful to NCInnovation for investing in this critical work and proud to support Dr. Bahr and his team as they advance life-changing solutions in the fight against neurodegenerative diseases.”

Dr. Bahr's research at the Robeson County public university focuses on a different type of treatment that could offer Alzheimer's patients a more accessible and affordable option.

"The current therapeutic that’s been newly approved by the FDA are called immuno-therapies, they’re actually human proteins that are very expensive to generate," Dr. Bahr told media outlet WPTF.

The NCInnovation R&D grant will help Dr. Bahr advance toward clinical trials. As WPTF reported, "The team at UNC Pembroke is currently doing testing on mice with the same human gene mutations that cause Alzheimer’s looking for improved memory, reduced eating due to nausea and changes in breathing."

Dr. Bahr said during the interview, "It takes an organization like NCInnovation to give us the confidence to move forward and approach the FDA and form the relationships with big companies in our state that really want to be game changers to try to treat dementia risk-factors long before you’re actually dealing with the Alzheimer’s disease."

Ico insights

INSIGHTS

SPONSORS' CONTENT
fayetteville-state-university greg-mcelveen headshott

Innovation Pathways & Partnerships returns on Oct. 3

Greg McElveen - Assistant Vice Chancellor for Strategic Initiatives and Executive Director, FSU Research Corp,, Fayetteville State University
systel-business-equipment madison-howard headshott

From Press to Possibilities: Systel’s New Online Print Storefront

Madison Howard - Marketing Team Leader, Systel Business Equipment
cape-fear-eye-associates cory-worrell headshott

CTAK (Corneal Tissue Addition for Keratoplasty): Groundbreaking Advancement in Keratoconus Treatment

Cory Worrell - Director of Marketing, Cape Fear Eye Associates

In The Current Issue

Thirty, purdy and sturdy

I have now completed three decades on Earth. And I don’t know how to feel about that. It’s one thing to be told you’re getting old by your great-aunt Gertrude, or to pass major life milestones like graduating from high school or college, but there’s


A toast to healthcare: Local heathcare safety net holds 'Toast of the Town' event to support critical fundraising push

For local nonprofit The CARE Clinic, financial sustainability depends entirely on private support—making the 25th annual Toast of the Town fundraising event on Sept. 18 a crucial component of the organization’s annual budget. Photo provided


Teeing up for success: The Bogey Brothers brings multi-sport simulators to Cameron

The Bogey Brothers, located in Cameron, N.C., has four multi-sport simulator bays that promise fun for all ages. Whether it’s your first time hitting a golf ball or you frequent the fairway, this venue offers a new way to experience the sport. In add